Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VMP and CDE Chemotherapy for HIV-Related NHL
NCT00002905Phase 2Unknown
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- Jun 1995
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide, mitoxantrone, prednimustine, cyclophosphamide, doxorubicin in non-Hodgkin lymphoma (NHL), sponsored by Centro di Riferimento Oncologico di Aviano. Status: unknown.
02
Drugs
etoposidemitoxantroneprednimustinecyclophosphamidedoxorubicin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00002905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002905.